HIGHLIGHTS
- who: Brett E. Phillips from the Institute of Cellular Therapeutics, Allegheny Health Network, th Floor South Tower, East North Pittsburgh, PA, USA have published the paper: Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist, in the Journal: (JOURNAL)
- what: In spite of the evidence linking neutrophils and CXCR2 to T2D and possibly T2D-associated NAFLD , to date there are no studies aimed at short-circuiting neutrophil function and neutrophil-driven inflammation independently of macrophages-well known participants in the progression of HFD pathology towards NAFLD/NASH . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.